Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Immunosyn Corp

+ Add to Watchlist

IMYN:US

0.0005 USD 0.00000.00%

As of 20:10:02 ET on 02/26/2015.

Company Profile for Immunosyn Corp (IMYN)

Immunosyn Corporation owns the exclusive worldwide license to market a biopharmaceutical drug used to treat chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers.

Contact Information

Immunosyn Corp

10815 Rancho Bernardo Road
Suite 101
San Diego, CA 92127
United States
Phone: 1-888-853-3663

Key Executives for Immunosyn Corp (IMYN)

Douglas A McClain JrChair/CFO/Chief Accounting OfcrStephen D FerronePresident/CEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil